Predictors of decreased libido in women during the late reproductive years

Menopause

Volumn 11, Issue 2, 2004, Pages 144-150

  Gracia, Clarisa R ^a,b   Sammel, Mary D ^a   Freeman, Ellen W ^a   Liu, Li ^a   Hollander, Lori ^a   Nelson, Deborah B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Penn Fertility Care   (United States)

Author keywords

Hormones; Libido; Menopause; Sexual dysfunction; Testosterone; Variability

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; FAMILY LIFE; FEMALE; HORMONE DETERMINATION; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MENOPAUSE; PROSPECTIVE STUDY; PSYCHOSOCIAL ENVIRONMENT; RISK FACTOR; SEXUAL DYSFUNCTION; SOCIOECONOMICS; VAGINAL DRYNESS; BLOOD; CLIMACTERIUM; COHORT ANALYSIS; LIBIDO; MIDDLE AGED; PSYCHOLOGY; PSYCHOSEXUAL DISORDER; UNITED STATES;

ADULT; BODY MASS INDEX; CLIMACTERIC; COHORT STUDIES; DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LIBIDO; LUTEINIZING HORMONE; MIDDLE AGED; PENNSYLVANIA; PROSPECTIVE STUDIES; PSYCHOLOGY; RISK FACTORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SOCIOECONOMIC FACTORS; TESTOSTERONE;

EID: 2342524665     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000082147.01218.CF     Document Type: Article

References (48)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-444.
2. Dennerstein L, Dudly E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001; 76:456-460.
3. Ilusti E, Piccone C, Mattei A, Di Stanislao C, Ficorella C, Marchetti P. Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori. 2002;88:128-130.
4. Pfeiffer E, Davis GC. Determinants of sexual behavior in middle and old age. J Am Geriatr Soc 1972;20:151-158.
5. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynaecol 1977;4:227-239.
6. Hawton K, Oath D, Day A. Sexual function in a community sample of middle-aged women with partners: effects of age, marital, socio-economic, psychiatric, gynecological, and menopausal factors. Arch Sex Behav 1994;23:375-395.
7. Osborn M, Hawton K, Gath D. Sexual dysfunction among middle-aged women in the community. BMJ 1988;296:959-962.
8. Dennerstein L, Smith A, Morse C, Burger H. Sexuality and the menopause. J Psychosom Obstet Gynaecol 1994;15:59-66.
9. Koster A, Garde K. Sexual desire and menopausal development in a prospective study of Danish women born in 1936. Maturitas 1992; 16:49-60.
10. Hallstrom T, Samuelsson S. Changes in women's sexual desire in middle life: the longitudinal study of women in Gothenburg. Arch Sex Behav 1990;19:259-268.
11. Reddish S. Loss of libido in menopausal women. Australian Familty Physician. 2002;31:427-432.
12. Sarrel PM, White head MI. Sex and menopause: defining the issues. Maturitas 1985;7:217-224.
13. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty four hour mean plasma testosterone concentration declines with age in normal premenopausal women. JCEM 1995;80:1429-1430.
14. Longcope C, Franz Z, Morello C, Baker R, Johnson CC Jr. Steroid and gonadotropin levels in women during the perimenopausal years. Maturitas 1986;8:189-196.
15. Longcope C. Adrenal and gonadal androgen secretion in normal females. JCEM 1986;15:213-228.
16. Longcope C. Hormone dynamics at the menopause. Ann NY Acad Sci 1990;592:21-30.
17. Quay AT. Screening for androgen deficiency in women: methodological and interpretive issues. Fert Steril 2002;77(Suppl 4):S83-S88.
18. Guay A, Davis SR. Testosterone insufficiency in women: fact or fiction? World J Oral 2002;20:106-110.
19. Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate levels in women with decreased libido. J Sex Marital Ther 2002;28:129-142.
20. Guay AT, Decreased testosterone in regularly menstruating women with decreased libido: a clinical observation. J Sex Marital Ther 2001;27:513-519.
21. Riley A, Riley E. Controlled studies on women presenting with sexual disorder: I. Endocrine status. J Sex Marital Ther 2000;26:269-283.
22. Sarrel PM. Androgen deficiency: menopause and estrogen-related factors. Fertil Steril 2002;77(Suppl 4):S63-S67.
23. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective cross-over study of sex steroid administration in the surgical menopause. Psychosom Med 1985; 47:339-351.
24. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397-409.
25. Simon J, Klaier E, Wiita B, Bowen A, Yang H-M. Differential effects of estrogen-androgena and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 1999;6:138-146.
26. Burger HG, Hailes J, Menelaus M, Nelson J, Hudson B, Balazs N. The management of persistent menopausal symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 1984;6:351-358.
27. Davis SR, McCloud PI, Strauss BSG, Burger H. Testosterone enhances estradiol effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-236.
28. Sarrel PM, Dobay B, Wiita B. Sexual behavior and neuroendocrine response in estrogen and estrogen-androgen replacement in post-menopausal women dissatisfied with estrogen-only therapy. J Reprod Med 1998;43:847-856.
29. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688.
30. Dennerstein L, Tandolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002; 77:42-48.
31. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
32. Bromberger JT, Meyer PM, Kravitz HM, et al. Psychological distress and natural menopause; a multiethnic community study. Am J Public Health 2001;91:1435-1442.
33. Morrison MG, Thomas TH, Freeman EW, Sammel MD, Grisso JA. DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years. Biol Psychiatry 2001;50:105-711.
34. Freeman EW, Sammel MD, Grisso JA, Battistini M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Womens Health Gend Based Med 2001;10:67-76.
35. Freeman EW, Grisso JA, Berlin JA, Sammel M, Garcia-Espana B, Hollander L. Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause 2001; 8:33-42.
36. Grisso JA, Freeman EW, Maurin E, Garcia-Espana B, Berlin JA. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999;14:98-103.
37. Manson JM, Sammel MD, Freeman EW, Grisso JA. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril 2001;75:297-304.
38. Radloff L. The CES-D scale: A new self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
39. Myers JK. Weissman MM. Use of a self-report symptom scale to detect depression in a community sample. Am J Psychiatry 1989; 147:1081-1084.
40. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: Free Press/Macmillan Inc., 1991.
41. Bloch M, Schmidt PG, Danaceau M, Murphy J, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:824-930.
42. Schmidt PJ, Neiman LK, Danaceau MA, Adams LF, Rubinaw DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual symdrome. N Engl J Med 1998; 338:209-216.
43. Judd HL, Yen SS. Serum androstenedione and testosterone levels during the menstrual cycle. Jclin Endocrinol Metab 1973;36:475-481.
44. Vierhapper H, Nowotny P, Waldhausl W. Determination of testosterone production rates in men and women using stable isotope dilution and mass spectrometry. J Clin Endocrinol Metab 1997;82:1492-7496.
45. Sinha-Hikim I, Arver S, Beall G, et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1998;83:1312-1318.
46. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888-889.
47. Jones LA. The use of validated questionnaires to assess female sexual dysfunction. World J Urol 2002;20:89-92.
48. Rosen RC. Assessment of female sexual dysfunction: review of validated methods. Fertil Steril 2002;77(Suppl 4):S89-S93.